Anti-BCMA CAR T Cells Myeloma Trials

Anti-BCMA CAR T Cells are a BCMA targeted CAR T Cell therapy being developed at the National Cancer Institute.

SparkCures ID	127
Generic Name	Anti-BCMA CAR T Cells
Treatment Classifications	Adoptive Cellular Therapy CAR T Cell
Treatment Targets	B-Cell Maturation Antigen (BCMA)

All Clinical Trials

View all active clinical trials around the US.

Verified

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

Anti-BCMA CAR T Cells